|
|
|
| Comparison of Short-term Clinical Efficacy of PKEP and HoLEP in the Treatment of Senile Benign Prostatic Hyperplasia |
| YU Xiao-long, HAN Hong-jia |
| Department of Urology, Chang'an hospital, Xi'an 710016, Shaanxi |
|
|
|
|
Abstract 【Objective】To compare the short-term clinical effects of transurethral plasma enucleation of the prostate (PKEP) and transurethral holmium laser enucleation of the prostate (HoLEP) in the treatment of senile benign prostatic hyperplasia (BPH). 【Methods】 A total of 68 patients with BPH treated in our hospital from March 2017 to may 2019 were selected as the research objects. They were randomly divided into HoLEP group and PKEP group, with 34 cases in each group. Patients in the PKEP group were treated with PKEP and patients in the HoLEP group were treated with HoLEP. The operation, clinical efficacy and incidence of adverse reactions were compared between the two groups. 【Results 】The amount of intraoperative bleeding in the HoLEP group was less than that in the PKEP group, and the operation time, urinary catheter retention time, hospital stay and bladder flushing time were significantly shorter than those in the PKEP group (P<0.05). At 1 and 6 months after operation, the prostate volume, RUV, QOL score and IPSS score of the two groups were lower than those before operation, and the Qmax was higher than that before operation. There was significant difference between the HoLEP group and the PKEP group (P<0.05). The total clinical effective rate in the HoLEP group was 91.18% (31/34), which was significantly higher than 70.59% (24/34) in the PKEP group(χ2 =4.660,P=0.031). The incidence of adverse reactions in the HoLEP group was 11.76% (4/34), which was significantly lower than 35.29% (12/34) in the PKEP group(χ2=5.231,P=0.022). 【Conclusion】 The clinical effect of HoLEP in the treatment of benign BPH in the elderly is better than PKEP. It can reduce the length of hospital stay, improve the quality of life and reduce postoperative complications.
|
|
Received: 30 October 2020
|
|
|
|
|
|
[1] 易明, 董自强, 侯毅, 等. HoLEP、PKRP治疗良性前列腺增生症临床效果比较[J].山东医药, 2017, 57(31):79-81.
[2] 朱瑞, 刘航, 李茂, 等. HoLEP治疗良性前列腺增生合并急性尿潴留的临床疗效及安全性研究[J].重庆医科大学学报, 2019,44(8):614-618.
[3] 李树人, 郑鸣, 蒋庆详, 等. HoLEP联合耻骨上小切口治疗高危良性前列腺增生合并大膀胱结石的疗效[J].中国老年学杂志, 2016, 36(07):139-140.
[4] 沈俊文,王荣江,高建国, 等.盆底功能锻炼结合微信随访对治疗前列腺癌根治术后尿失禁的疗效评估[J].泌尿外科杂志(电子版),2019,11(1):23-32.
[5] 张豪杰, 盛璐, 陈然, 等. 经尿道钬激光前列腺剜除术与经尿道等离子前列腺剜除术治疗前列腺增生的疗效比较[J].中国临床医学, 2016, 23(5):636-639.
[6] 王志民, 赵文波, 孙朝晖,等. TURP与HoLEP治疗高龄良性前列腺增生的临床疗效比较[J].临床合理用药杂志, 2015,12(25):154-155.
[7] TAKAYUKI S.Clinical outcomes of anteroposterior dissection holmium laser enucleation of the prostate for benign prostatic hyperplasia[J].Hinyokika Kiyo Acta Urologica Japonica,2016, 62(9):449-453.
[8] 陈卓, 袁晓亮, 张亚杰. 经尿道前列腺钬激光剜除术和经尿道前列腺电切术治疗良性前列腺增生比较[J].中华老年多器官疾病杂志, 2018,18(8):705-708.
[9] 王伟, 杨建军, 杨关天, 等. 经尿道前列腺钬激光剜除术联合济生肾气汤加味治疗BPH的临床疗效分析[J].中华男科学杂志, 2019,25(4):351-355.
[10] QIAN X , LIU H , XU D , et al. Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis[J].Aging Male,2017,22(3):1-8. |
|
|
|
2021, Vol. 38 
